AI In Healthcare Market

Key Players: Companies such as Siemens Healthineers (DE), IBM (US), Philips (NL), GE Healthcare (US), CureMetrix (US), Aidoc (IL), Zebra Medical Vision (IL), CureMetrix (US) are some of the major participants in the global market.

AI In Healthcare Market

AI In Healthcare Market Research Report: Size, Share, Trend Analysis By Applications (Medical Imaging, Predictive Analytics, Robotic Surgery, Clinical Trials, Virtual Health Assistants), By Technology (Machine Learning, Natural Language Processing, Computer Vision, Deep Learning), By End Use (Hospitals, Pharmaceutical Companies, Research Institutions, Diagnostic Centers) - Growth Outlook & Industry Forecast 2025 To 2035
ID: MRFR/HS/4226-CR
144 Pages
Rahul Gotadki, Kinjoll Dey
Last Updated: June 05, 2026
Request Free Sample

AI In Healthcare Market Summary

Global AI in Healthcare Market Size was valued at USD 0.514 Billion in 2024 & the market is projected to grow from USD 0.642 Billion in 2025 to USD 5.81 Billion by 2035, registering a CAGR of 24.91% during the forecast period 2025–2035. North America led the market with over 45% share, generating around USD 0.29 Billion in revenue.
 
The increasing adoption of AI-powered diagnostic and clinical decision-support solutions is a major growth driver for the AI In Healthcare Market. Healthcare providers are leveraging artificial intelligence to improve diagnostic accuracy, optimize treatment planning, reduce operational burdens, and enhance patient outcomes.
 
The Stanford Center for Artificial Intelligence in Medicine and Imaging dataset index hosts 100+ AI-ready healthcare datasets spanning radiology, pathology, ophthalmology, and clinical applications. The growing availability of large-scale medical datasets is accelerating AI model development, supporting broader adoption of AI-driven diagnostics and healthcare decision-making worldwide.

Key Market Trends & Highlights

The AI In Healthcare Market is poised for substantial growth driven by technological advancements and increasing demand for personalized solutions.

  • North America led the AI In Healthcare Market with over 45% of global revenue in 2024.
  • Europe AI In Healthcare Market reached USD 0.19 billion in 2024, accounting for approximately 29.60% global market share.
  • Electronic Health Records accounted for approximately 52% market share in 2024, remaining the leading healthcare AI data source.
  • Hospitals represented nearly 48% of total market demand in 2024, reflecting strong institutional AI adoption.
  • Cloud-based deployment captured approximately 45% market share in 2024, driven by scalable healthcare analytics infrastructure.
  • Machine Learning held approximately 41% revenue share in 2024, supporting predictive analytics and personalized healthcare applications.

Market Size & Forecast

2024 Market Size 0.503 (USD Billion)
2035 Market Size 5.81 (USD Billion)
CAGR (2025 - 2035) 24.91%

Major Players

Companies such as Siemens Healthineers (DE), IBM (US), Philips (NL), GE Healthcare (US), CureMetrix (US), Aidoc (IL), Zebra Medical Vision (IL), CureMetrix (US) are some of the major participants in the global market.

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

AI In Healthcare Market Trends

The AI In Healthcare Market is currently experiencing a transformative phase, characterized by the integration of advanced technologies into various healthcare sectors. This evolution appears to be driven by a growing demand for improved patient outcomes, operational efficiency, and cost reduction. Governments in the region are actively promoting the adoption of artificial intelligence in healthcare, recognizing its potential to enhance diagnostic accuracy, streamline administrative processes, and facilitate personalized medicine. As a result, healthcare providers are increasingly investing in AI solutions, which may lead to a more data-driven approach in patient care and management.

Moreover, the regulatory landscape is evolving to accommodate the rapid advancements in artificial intelligence technologies. Initiatives aimed at fostering innovation and ensuring patient safety are being implemented, which could further stimulate growth in the AI In Healthcare Market. Collaboration between public and private sectors is also on the rise, suggesting a collective effort to harness the benefits of AI in healthcare. This collaborative environment may pave the way for new partnerships and innovations, ultimately enhancing the quality of healthcare services across the region.

Increased Investment in AI Technologies

Healthcare providers in the region are likely to increase their investments in artificial intelligence technologies. This trend suggests a shift towards adopting AI-driven solutions for diagnostics, treatment planning, and patient management, which may enhance overall healthcare delivery.

  • Siemens Healthineers continues advancing product development and innovation through AI-enabled imaging, clinical decision support, and workflow automation platforms. Strategic partnerships and collaborations with healthcare providers and research institutions are expanding AI deployment across diagnostic pathways, supporting faster clinical decisions and improved operational efficiency as healthcare organizations increase investments in artificial intelligence technologies.

Regulatory Framework Development

The development of a robust regulatory framework for artificial intelligence in healthcare appears to be a priority for global governments. This initiative indicates a commitment to ensuring the safe and effective use of AI technologies, which could foster greater trust among healthcare providers and patients.

  • IBM has strengthened its healthcare AI portfolio through strategic acquisitions, platform expansion, and regulatory-compliant AI solutions. Clinical advancements and regulatory alignment initiatives are supporting broader adoption of trustworthy AI systems, enabling healthcare organizations to implement advanced analytics while meeting evolving governance, transparency, and patient safety requirements across healthcare environments.

Focus on Data Security and Privacy

As the AI In Healthcare Market expands, there is a growing emphasis on data security and patient privacy. This trend suggests that stakeholders are increasingly aware of the importance of safeguarding sensitive health information, which may lead to the implementation of stricter data protection measures.

  • Philips continues investing in product development and innovation across secure connected-care ecosystems and AI-enabled healthcare platforms. Regulatory approvals and compliance-focused clinical technologies support stronger protection of patient information while enabling advanced analytics, reinforcing healthcare providers’ confidence in adopting AI solutions that prioritize cybersecurity, privacy, and clinical effectiveness.

AI In Healthcare Market Drivers

Government Initiatives and Funding

Government initiatives play a pivotal role in shaping the AI In Healthcare Market. Various nations have launched strategic plans aimed at integrating AI into healthcare systems. For example, Saudi Arabia's Vision 2030 emphasizes the adoption of advanced technologies, including AI, to enhance healthcare delivery. 
 
The government has allocated substantial funding to support research and development in AI applications, which is expected to foster innovation and attract private sector investments. Additionally, the Qatar National Vision 2030 outlines similar objectives, focusing on improving healthcare services through technology. These initiatives not only enhance the infrastructure for AI in healthcare but also create a conducive environment for collaboration between public and private entities, thereby accelerating the growth of the market.

  • According to World Bank data, global healthcare expenditure exceeded 10% of world GDP in recent years, reflecting strong public-sector commitment toward healthcare modernization. Growing government investments in digital health infrastructure, research programs, and advanced technologies are creating favorable conditions for AI adoption and innovation throughout healthcare systems.

Growing Focus on Operational Efficiency

The AI In Healthcare Market is increasingly focused on enhancing operational efficiency within healthcare organizations. AI technologies are being deployed to streamline administrative tasks, manage patient flow, and optimize resource utilization. For example, hospitals in the UAE are implementing AI-driven scheduling systems that reduce patient wait times and improve overall service delivery.
 
This focus on operational efficiency is expected to result in cost savings and improved patient experiences, which are crucial for the sustainability of healthcare systems in the region. The market for AI solutions aimed at operational efficiency is projected to grow, with estimates suggesting a potential increase of 15% in adoption rates over the next few years. This trend underscores the importance of AI in driving efficiency within the healthcare sector.

  • PubMed studies demonstrate that AI-assisted workflow optimization can significantly reduce administrative burdens and improve healthcare resource utilization. Research reports measurable reductions in reporting times and operational inefficiencies, supporting healthcare organizations' growing adoption of AI technologies to improve productivity, patient flow management, and service delivery performance.

Integration of AI in Diagnostic Processes

The integration of AI in diagnostic processes is transforming the AI In Healthcare Market. AI algorithms are increasingly being utilized to analyze medical images, pathology reports, and genetic data, leading to faster and more accurate diagnoses. For instance, hospitals in Bahrain have begun employing AI tools to assist radiologists in identifying anomalies in imaging studies, which has reportedly improved diagnostic accuracy by up to 30%. 
 
The market for AI-driven diagnostic tools is expected to expand significantly, with projections indicating a growth rate of approximately 25% annually. This integration not only enhances clinical outcomes but also optimizes resource allocation within healthcare facilities, making it a critical driver for the market.

  • IHME data indicate that chronic diseases account for a substantial proportion of global healthcare burden, increasing demand for earlier and more accurate diagnosis. AI-enabled diagnostic tools are helping healthcare systems address growing disease prevalence through improved detection capabilities, supporting broader implementation of AI-assisted imaging and clinical assessment technologies.

Advancements in Telemedicine and Remote Monitoring

Advancements in telemedicine and remote monitoring are significantly influencing the AI In Healthcare Market. The rise of AI-powered telehealth platforms enables healthcare providers to offer remote consultations and continuous patient monitoring, thereby improving access to care. Countries like Oman are investing in telemedicine initiatives that leverage AI to enhance patient outcomes, particularly in rural areas. 
 
The market for telemedicine solutions in the global market is anticipated to grow at a robust pace, with projections indicating a compound annual growth rate of around 30% over the next five years. This growth is likely to be fueled by the increasing acceptance of digital health solutions among patients and providers alike, further solidifying the role of AI in transforming healthcare delivery across the GCC.
 

  • World Bank digital development indicators show rapidly increasing internet connectivity and digital health accessibility worldwide. Expanding digital infrastructure supports greater adoption of AI-powered telemedicine platforms and remote monitoring solutions, enabling healthcare providers to extend care access while improving patient engagement and clinical oversight.

Rising Demand for Personalized Healthcare Solutions

The AI In Healthcare Market is witnessing a notable shift towards personalized healthcare solutions. This trend is driven by an increasing patient expectation for tailored treatments and services. AI technologies enable healthcare providers to analyze vast amounts of patient data, leading to more accurate diagnoses and customized treatment plans.
 
For instance, the UAE has implemented AI-driven platforms that assess individual health profiles, thereby enhancing patient engagement and satisfaction. The market for personalized medicine in the global market is projected to grow significantly, with estimates suggesting a compound annual growth rate of over 20% in the coming years. This rising demand for personalized solutions is likely to propel investments in AI technologies, further solidifying the GCC's position in the global healthcare landscape.
 

  • PubMed research highlights substantial growth in precision medicine and personalized treatment approaches supported by AI-driven analytics. Studies show AI can process complex patient datasets to identify individualized therapeutic pathways, supporting improved treatment effectiveness and accelerating demand for personalized healthcare technologies.

Market Segment Insights

By Application: Clinical Decision Support (Largest) vs. Medical Imaging (Fastest-Growing)

The market is significantly shaped by various applications, with clinical decision support systems commanding the largest share of 34% in the AI In Healthcare Market. By enhancing diagnostic accuracy and treatment efficacy, these systems yield substantial benefits for healthcare providers. Following closely is Medical Imaging, which is rapidly gaining momentum due to advancements in imaging technologies powered by AI, driving its adoption across various healthcare settings. Recent trends indicate an accelerated growth trajectory within the Medical Imaging sector as it integrates AI technologies, revolutionizing image analysis and interpretation. Moreover, the push towards personalized medicine and early disease detection is propelling the demand for Clinical Decision Support tools. Collaborations between tech firms and healthcare organizations are also pivotal in enhancing existing solutions, fostering innovation across the entire application segment.

Siemens Healthineers continues expanding AI-enabled clinical decision support capabilities across imaging and diagnostic workflows. Clinical Decision Support represented approximately 34% of the AI In Healthcare Market in 2024, reflecting strong healthcare demand for technologies that improve diagnostic accuracy, treatment planning, and evidence-based clinical decision-making.

By End Use: Hospitals (Largest) vs. Home Healthcare (Fastest-Growing)

In the AI In Healthcare Market, hospitals represent the largest segment by end use, accounting for 48%, leveraging AI technologies to enhance patient care, streamline operations, and improve diagnostic accuracy. Diagnostic centers and pharmaceutical companies also hold significant shares, harnessing AI for advancements in imaging and drug development respectively. Research institutions are pivotal in innovating AI applications, contributing to a growing percentage of the market as well.

IBM supports hospital digital transformation through AI-powered analytics, workflow automation, and decision-support platforms. Hospitals accounted for approximately 48% market share in 2024, driven by extensive investments in AI technologies aimed at improving patient outcomes, operational efficiency, and healthcare resource management.

By Technology: Machine Learning (Largest) vs. Natural Language Processing (Fastest-Growing)

Machine learning holds the largest share in the AI In Healthcare Market at 41%, driven by its versatility and ability to analyze vast datasets for predictive analytics and personalized treatment plans. Natural Language Processing, although smaller in market share compared to Machine Learning, is the fastest-growing segment, facilitating improved communication between patients and healthcare providers through text and speech recognition technologies. Both technologies are pivotal in enhancing operational efficiencies in healthcare delivery.

Philips continues leveraging machine learning algorithms across imaging, patient monitoring, and predictive healthcare applications. Machine Learning captured approximately 41% of AI In Healthcare Market revenue in 2024, reflecting its critical role in predictive analytics, disease detection, and personalized treatment recommendations.

By Deployment Model: Cloud-Based (Largest) vs. Hybrid (Fastest-Growing)

In the AI In Healthcare Market, the deployment model segment is primarily dominated by cloud-based solutions, which hold the largest market share at 45%. These solutions offer scalable resources and flexibility, appealing to healthcare providers looking for efficient data management and analytics capabilities. On-premises deployment follows, as it provides enhanced data control and security, attracting organizations with stringent compliance needs. Companies are increasingly opting for hybrid solutions, combining both cloud and on-premises benefits, to optimize their operational capabilities.

Cloud-Based (Dominant) vs. Hybrid (Emerging)

Cloud-based deployment models are dominating the market, providing organizations with extensive scalability, reduced IT overhead, and enhanced collaboration. This model is particularly favored by smaller healthcare facilities and startups that require low startup costs and rapid deployment. In contrast, hybrid models are emerging swiftly, reflecting a growing trend among larger institutions that need to leverage existing on-premises resources while also benefiting from the cloud's flexibility. The hybrid model allows healthcare providers to maintain critical data on-site for regulation compliance while utilizing the cloud for advanced analytics and processing capabilities, making it an attractive compromise.

By Data Source: Electronic Health Records (Largest) vs. Wearable Devices (Fastest-Growing)

Electronic Health Records (EHRs) dominate the AI In Healthcare Market, accounting for a significant 52% share of the data sources utilized. EHRs are critical in aggregating patient information, streamlining clinical workflows, and advancing research capacities. Their established usage and integration into healthcare systems solidify their predominant market share, while wearable devices, once considered supplementary, are experiencing rapid uptake as technological advancements enhance their practicality and accessibility. Wearable devices are emerging as a robust segment, driven by increasing health consciousness and the pursuit of personalized healthcare solutions. Their ability to provide real-time health data and insights fosters patient engagement and compliance with treatment regimens. The momentum of wearable technology, coupled with innovations in AI, signals a profound shift in how healthcare data is sourced and utilized, marking a transformative era in patient care and medical research.

EHRs (Dominant) vs. Wearable Devices (Emerging)

Electronic Health Records (EHRs) are the cornerstone of the market, offering a comprehensive digital record of patient health information that is essential for effective care coordination and clinical decision-making. Their integration into healthcare workflows enables clinicians to access real-time data, leading to improved patient outcomes and operational efficiencies. As the dominant data source, EHRs continue to evolve, incorporating advanced analytics and AI features that enhance predictive insights and support population health management. Conversely, wearable devices represent an emerging data source, driven by innovation and a consumer shift towards proactive health monitoring. These devices, which include smartwatches and fitness trackers, collect a range of biometric data, enabling continuous health tracking and personalized care interventions. As wearables become increasingly sophisticated and integrated with healthcare systems, they are set to play a pivotal role in the future of healthcare delivery, enhancing patient engagement and informing treatment strategies.

Get more detailed insights about AI In Healthcare Market
Request Free Sample

Regional Insights

North America : Innovation and Investment Hub

North America leads in the AI In Healthcare Market size, accounting for over 45% of the global revenue in 2024. The region benefits from significant investments in technology, a robust healthcare infrastructure, and a growing demand for AI-driven solutions to enhance patient care and operational efficiency. Regulatory support from agencies like the FDA further catalyzes innovation, ensuring safety and efficacy in AI applications.

  • CDC data indicate that approximately 6 in 10 U.S. adults live with at least one chronic disease, while 4 in 10 live with two or more chronic conditions. The growing burden of chronic illnesses is accelerating healthcare providers’ adoption of AI technologies for early diagnosis, disease management, and operational optimization across North America.

The United States dominates this landscape, with key players such as IBM, Google, and Microsoft leading the charge. The competitive environment is characterized by rapid technological advancements and collaborations between tech companies and healthcare providers. This synergy fosters the development of cutting-edge AI solutions, positioning North America as a leader in the market.

  • GE Healthcare continues expanding AI-enabled imaging, precision diagnostics, and digital healthcare solutions. The company’s ongoing investments in AI-powered clinical workflows and decision-support technologies reinforce North America's leadership in healthcare AI innovation and adoption across hospitals and healthcare systems.

Europe : Regulatory Framework and Growth

Europe AI In Healthcare Market size was valued at USD 0.19 billion in 2024, making it the second-largest regional market with a 30% share. The region's growth is driven by increasing healthcare expenditures, a rising aging population, and a strong emphasis on digital transformation in healthcare. Regulatory frameworks, such as the EU's GDPR and the Medical Device Regulation, provide a structured environment for AI innovations, ensuring compliance and patient safety.

  • The European Medicines Agency (EMA) continues supporting innovation through structured regulatory frameworks that facilitate the safe integration of advanced digital health and AI technologies. These regulatory initiatives strengthen confidence among healthcare providers and technology developers, supporting sustained growth of AI-driven healthcare solutions throughout Europe.

Leading countries in this region include Germany, the UK, and France, where companies like Siemens Healthineers and Philips are making significant strides. The competitive landscape is marked by a mix of established firms and innovative startups, all vying to leverage AI for improved diagnostics and patient outcomes. This dynamic environment fosters collaboration and investment, propelling the European market forward.

Asia-Pacific : Emerging Market with Potential

Asia-Pacific is an emerging powerhouse in the AI In Healthcare Market, holding about 20% of the global share. The region's growth is fueled by increasing healthcare demands, technological advancements, and government initiatives promoting digital health solutions. Countries like China and India are investing heavily in AI technologies to enhance healthcare delivery and accessibility, supported by favorable regulatory environments that encourage innovation. 

China is leading the charge, with significant contributions from local companies and partnerships with global tech giants. The competitive landscape is evolving, with a mix of established players and startups focusing on AI applications in diagnostics, treatment planning, and patient management. This vibrant ecosystem is set to drive substantial growth in the Healthcare AI sector across Asia-Pacific.

Middle East and Africa : Resource-Rich and Growing Market

The Middle East and Africa region is gradually emerging in the AI In Healthcare Market, holding around 5% of the global share. Growth is driven by increasing investments in healthcare infrastructure, a rising prevalence of chronic diseases, and government initiatives aimed at enhancing healthcare delivery through technology. Countries like the UAE and South Africa are at the forefront, implementing AI solutions to improve patient outcomes and operational efficiency. 

The competitive landscape is characterized by a mix of local and international players, with a focus on partnerships and collaborations to leverage AI technologies. The region's unique challenges, such as resource constraints, are being addressed through innovative solutions, making it a promising market for Healthcare AI advancements.

AI In Healthcare Market Regional Image

Key Players and Competitive Insights

The AI In Healthcare Market is currently characterized by a dynamic competitive landscape, driven by rapid technological advancements and increasing demand for efficient healthcare solutions. Key players such as Siemens Healthineers (DE), IBM (US), and GE Healthcare (US) are strategically positioned to leverage innovation and partnerships to enhance their market presence. Siemens Healthineers (DE) focuses on integrating AI into imaging solutions, while IBM (US) emphasizes its Watson Health platform to provide data-driven insights. GE Healthcare (US) is actively pursuing digital transformation initiatives, enhancing its AI capabilities to improve patient outcomes. Collectively, these strategies foster a competitive environment that prioritizes technological innovation and collaborative efforts.
 
In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure appears moderately fragmented, with several players vying for market share. However, the influence of major companies is significant, as they set benchmarks for technological advancements and operational standards. This competitive structure encourages smaller firms to innovate and differentiate their offerings, thereby contributing to a vibrant market ecosystem.
 
In December 2025, Siemens Healthineers (DE) announced a partnership with a leading regional hospital network to implement AI-driven diagnostic tools aimed at improving patient care. This strategic move underscores the company's commitment to enhancing healthcare delivery through advanced technology, potentially positioning it as a leader in AI integration within the region. The collaboration is expected to yield significant improvements in diagnostic accuracy and operational efficiency.
 
In November 2025, IBM (US) launched an AI-powered analytics platform tailored for healthcare providers in the GCC. This initiative aims to streamline data management and enhance decision-making processes. By harnessing the power of AI, IBM seeks to empower healthcare professionals with actionable insights, thereby improving patient outcomes and operational workflows. This strategic action reflects IBM's focus on leveraging AI to address specific regional healthcare challenges.
 
In October 2025, GE Healthcare (US) unveiled a new AI-based imaging solution designed to assist radiologists in detecting anomalies more effectively. This innovation is particularly relevant in the GCC, where there is a growing demand for advanced diagnostic tools. By enhancing the capabilities of radiologists, GE Healthcare (US) aims to improve diagnostic accuracy and reduce turnaround times, thereby solidifying its competitive position in the market.
 
As of January 2026, the competitive trends in the AI In Healthcare Market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances among key players are shaping the landscape, fostering innovation and collaboration. Looking ahead, it is likely that competitive differentiation will evolve, with a shift from price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition may redefine market dynamics, emphasizing the importance of strategic partnerships and cutting-edge solutions.

Key Companies in the AI In Healthcare Market include

Industry Developments

DEC 2025 - AI adoption in healthcare is accelerating as hospitals and life-science companies invest heavily in automation, predictive analytics, and clinical decision-support tools. Breakthroughs in imaging AI and workflow automation are driving new regulatory approvals, with governments issuing frameworks to ensure responsible AI deployment. Tech vendors are partnering with hospital networks to develop scalable, cloud-based AI ecosystems. The industry is now shifting from pilot projects to full operational integration, signaling a new era of digital healthcare efficiency.

Recent developments in the AI In Healthcare Market have showcased significant advancements and investments. In September 2023, Amazon unveiled its AI-driven healthcare platform aimed at improving patient diagnostics and operational efficiency. IBM has also strengthened its AI capabilities by announcing a partnership with Siemens Healthineers to enhance imaging solutions. In August 2023, NVIDIA expanded its AI healthcare portfolio, focusing on genomics and drug discovery, with substantial investments in Research and Development.

Meanwhile, Cerner and Microsoft solidified their alliance to integrate AI into electronic health record systems, enhancing data analysis and patient management. Growth in market valuation is evident, as Google and Philips reported increased adoption rates of AI technologies, projected to boost efficiency and reduce costs.

Furthermore, in recent months, Medtronic announced its acquisition of a predictive analytics firm, signaling a strategic move toward advanced AI-driven medical devices. Major happenings over the past 2-3 years reflect a surge in AI applications in diagnostics, treatment personalization, and operational efficiencies across the industry, indicating a robust and rapidly evolving landscape for Healthcare AI on a global scale.

Industry News 

Qure.ai : Johnson & Johnson Medtech Partners with Qure.ai to Boost Early Detection of Lung Cancer May 2025

  • This partnership aims to leverage AI for improved early detection of lung conditions.

Sanofi : Digital Transformation and Artificial Intelligence June 2025

  • Sanofi highlights its commitment to building and deploying AI-based solutions across its value chain, from research and development to manufacturing and patient engagement. They categorize their AI use into "Expert AI," "Snackable AI," and "Generative AI" to accelerate discovery, development, and delivery.

Johnson & Johnson : 6 ways Johnson & Johnson is using AI to help advance healthcare Oct 2024

  • J&J details how they are using AI to analyze operating room data for efficiency and learning, improve surgical procedures (e.g., cardiac ablation with CARTO™ 3 System's deep learning), and explore AI for presurgical planning and post-op patient tracking.

care.ai :2024 KLAS Emerging Solutions Top 20 Nov 2024

  • care.ai was recognized in the KLAS Emerging Solutions Top 20 report

Future Outlook

AI In Healthcare Market Future Outlook

The AI In Healthcare Market size is projected to reach USD 5.81 Billion by 2035, growing at a CAGR of 24.91%, driven by technological advancements and increasing healthcare demands.

New opportunities lie in:

  • Development of AI-driven telemedicine platforms for remote patient monitoring. Integration of predictive analytics in hospital management systems. Creation of personalized medicine solutions using AI algorithms.

By 2035, the market is expected to be a pivotal component of the healthcare landscape.

Market Segmentation

AI In Healthcare Market End Use Outlook

  • Hospitals
  • Diagnostic Centers
  • Research Institutions
  • Pharmaceutical Companies
  • Home Healthcare

AI In Healthcare Market Technology Outlook

  • Machine Learning
  • Natural Language Processing
  • Computer Vision
  • Deep Learning
  • Expert Systems

AI In Healthcare Market Application Outlook

  • Clinical Decision Support
  • Medical Imaging
  • Robotic Surgery
  • Patient Monitoring
  • Drug Discovery

AI In Healthcare Market Data Source Outlook

  • Electronic Health Records
  • Wearable Devices
  • Clinical Trials
  • Patient Surveys

AI In Healthcare Market Deployment Model Outlook

  • On-Premises
  • Cloud-Based
  • Hybrid

Report Scope

MARKET SIZE 2024 0.503(USD Billion)
MARKET SIZE 2025 0.642(USD Billion)
MARKET SIZE 2035 5.81(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 24.91% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Siemens Healthineers (DE), IBM (US), Philips (NL), GE Healthcare (US), CureMetrix (US), Aidoc (IL), Zebra Medical Vision (IL), CureMetrix (US)
Segments Covered Application, End Use, Technology, Deployment Model, Data Source
Key Market Opportunities Integration of predictive analytics in patient management systems enhances efficiency in the market.
Key Market Dynamics Growing adoption of artificial intelligence in healthcare enhances patient outcomes and operational efficiencies amid regulatory advancements.
Countries Covered GCC

FAQs

What is the current valuation of the AI In Healthcare Market in 2025?

The AI In Healthcare Market is valued at 27.5 USD Billion in 2024 and is projected to grow significantly.

What is the projected market size for the market by 2035?

The market is expected to reach a valuation of 158.4 USD Billion by 2035.

What is the expected CAGR for the AI In Healthcare Market during the forecast period 2025 - 2035?

The expected CAGR for the AI In Healthcare Market during the forecast period 2025 - 2035 is 17.25%.

Which companies are considered key players in the market?

Key players in the market include IBM, Google, Microsoft, Amazon, Siemens Healthineers, Philips, GE Healthcare, NVIDIA, CureMetrix, and Aidoc.

What are the main applications of healthcare artificial intelligence and their market valuations?

Main applications include Clinical Decision Support valued at 23.2 USD Billion and Medical Imaging at 36.5 USD Billion by 2035.

How does the AI In Healthcare Market segment by end use?

By end use, hospitals are projected to reach 58.0 USD Billion, while diagnostic centers may reach 30.0 USD Billion by 2035.

What technologies are driving the market?

Technologies such as Machine Learning, expected to reach 60.0 USD Billion, and Natural Language Processing, projected at 30.0 USD Billion, are key drivers.

What deployment models are prevalent in the market?

The market segments by deployment model include Cloud-Based solutions, anticipated to grow to 90.0 USD Billion by 2035.

What data sources are utilized in the market?

Data sources include Electronic Health Records, projected to reach 58.0 USD Billion, and Wearable Devices, expected to grow to 40.0 USD Billion.

How does the AI In Healthcare Market's growth compare across different segments?

The market shows varied growth, with Drug Discovery potentially reaching 53.7 USD Billion and Robotic Surgery at 17.0 USD Billion by 2035.
Author
Author
Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Co-Author
Co-Author Profile
Kinjoll Dey LinkedIn
Senior Research Analyst
He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get In Touch
Leave a Comment

Research Approach

 

Secondary Research

The secondary research process involved comprehensive analysis of regulatory databases, peer-reviewed medical journals, AI research publications, and authoritative health technology organizations. Key sources included the US Food & Drug Administration (FDA) [AI/ML-Based Medical Devices Database], European Medicines Agency (EMA) [AI Innovation Board Guidelines], HealthIT.gov [Office of the National Coordinator for Health Information Technology], National Institutes of Health (NIH) [National Library of Medicine AI in Healthcare Archives], Healthcare Information and Management Systems Society (HIMSS), Radiological Society of North America (RSNA) [AI Imaging Standards], Advanced Medical Technology Association (AdvaMed), Organization for Economic Co-operation and Development (OECD) [Health Statistics], World Health Organization (WHO) [Global Strategy on Digital Health], UN International Telecommunication Union (ITU) [AI for Health Framework], National Health Service (NHS) England [AI Lab Publications], European Commission [High-Level Expert Group on AI Documents], and national AI strategy reports from key markets. These sources were used to collect algorithmic approval data, clinical validation studies, deployment statistics, regulatory pathway analysis, and technology landscape mapping for machine learning platforms, natural language processing tools, computer vision systems, and deep learning diagnostic applications.

 

Primary Research

To gather both qualitative and quantitative information, the primary research process involved interviewing players from both the supply and demand sides. On the supply side, we found healthcare AI developers, medical imaging software providers, and health IT manufacturers, as well as chief technology officers (CTOs), heads of artificial intelligence strategy, managers of regulatory affairs, and sales leaders from these companies. In terms of demand-side sources, we have CMIOs, CDOs, radiology department heads, hospital IT directors, procurement leaders from IDNs, research directors from pharmaceutical companies and academic medical institutes, and others. Through primary research, we were able to confirm the development timelines of AI algorithms, validate the market segmentation across medical imaging and clinical decision support applications, and gain insights into the barriers to clinical adoption, costs of integration with existing EHR systems, and reimbursement pathways for AI-driven diagnostics.

Primary Respondent Breakdown:

By Designation: C-level & Board Level (40%), Director & VP Level (30%), Manager & Technical Leads (30%)

By Region: North America (40%), Europe (25%), Asia-Pacific (28%), Rest of World (7%)

 

Market Size Estimation

Global market valuation was derived through revenue mapping and deployment volume analysis. The methodology included:

Identification of 60+ key technology developers and healthcare AI vendors across North America, Europe, Asia-Pacific, and Middle East

Product mapping across machine learning platforms, natural language processing tools, computer vision systems, deep learning algorithms, and robotic process automation

Analysis of reported and modeled annual revenues specific to healthcare AI portfolios, including software licensing, platform subscriptions, and professional services

Coverage of manufacturers and software vendors representing 75-80% of global market share in 2024

Extrapolation using bottom-up (deployment volume × Average Selling Price by clinical application and care setting) and top-down (vendor revenue validation against health system IT spending) approaches to derive segment-specific valuations for medical imaging AI, clinical decision support systems, drug discovery platforms, and administrative workflow automation tools.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Customer Stories

Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.